Update on Stock Availability of Mounjaro® (tirzepatide)

Update 31 October 2024:

To improve the supply situation, Eli Lilly Australia (Lilly) commenced a transition period where Mounjaro® (tirzepatide) single-use vials are being replaced with Mounjaro (tirzepatide) multi-use KwikPen.

There are currently no shortages in place for Mounjaro in the multi-use KwikPen presentation. The vial presentation of Mounjaro is unavailable except in the 5mg dose (1). Information on supply of Mounjaro vials is available on the Therapeutic Goods Administration TGA medicines shortage reports database.

Lilly is committed to ongoing replenishment of all doses of the Mounjaro KwikPen presentation. As part of our commitment to supplying Mounjaro in Australia, Lilly continues to invest and add manufacturing capacity around the world. We have commenced incretin production at our manufacturing facility in North Carolina, in the U.S., with additional actions and expansions at other sites around the globe.

For patients

During this transition period, availability of Mounjaro vials across pharmacists may vary. Patients unable to fill their Mounjaro vial prescriptions are advised to consult with their Healthcare Professional.

In the instance that you miss a dose of Mounjaro, please consult your healthcare professional and follow the instructions contained in the Mounjaro Vial Consumer Medicine Information(2) or Mounjaro KwikPen Consumer Medicine Information(3).

For prescribers & pharmacists

Healthcare professionals requiring further medical or scientific information about Mounjaro may contact the Lilly Medical information team on 1800 454 559 / 1800 4 LILLY (operating hours are Monday to Friday, 9am – 5pm AEST).

References

  1. Australian Department of Health, Therapeutic Goods Administration, available at Medicine Shortages Information Initiative | Therapeutic Goods Administration (TGA). Accessed October 2024.

  2. Mounjaro Vial Consumer Medicine Information. Available at: https://rss.medsinfo.com.au/ly/cmi.cfm?product=lycmouna10823. Accessed October 2024.

  3. Mounjaro KwikPen Consumer Medicine Information. Available at: https://rss.medsinfo.com.au/ly/cmi.cfm?product=lycmounk10824. Accessed October 2024.

Mounjaro® is a registered trademark of Eli Lilly and Company.

Eli Lilly Australia Pty Limited, Level 9, 60 Margaret Street, Sydney, NSW 2000, Australia. ABN 39 000 233 922. Prepared October 2024. PP-TR-AU-0339.